Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT: Transperineal vs Transrectal Prostate Biopsy
NCT04843566Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Mar 2021
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Weill Cornell Medicine. Primary endpoint: Percentage of Subjects That Experienced Infection, Urinary Retention or Bleeding Requiring Intervention at 7 days. Started Mar 2021; status: completed.
Beyond the preview
Go deeper on NCT04843566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04843566.